Genentech Says It Shouldn't Lose Patent Rights Over Error
Genentech urged the Court of Appeal on Thursday to overlook a mistake made by one of its agents that threatens to prematurely end certain patent rights it has for its eye-disease...To view the full article, register now.
Already a subscriber? Click here to view full article